Ralf A. Hoffmann
Geen lopende functies
Profiel
Mr. Ralf A.
Hoffmann is Founder at AMP-Therapeutics GmbH and Head of Research at Deutsche Bank AG.
He joined Deutsche Bank in 1996.
He is Head of Global Macro and Risk Analysis.
From 2002 to 2010, he was Head of Global Risk Analysis at Deutsche Bank in London.
Mr. Hoffmann received Master degrees in economics from the University of Passau and in Southeast Asian studies from the University of London.
Eerdere bekende functies van Ralf A. Hoffmann
| Bedrijven | Functie | Einde |
|---|---|---|
AMP-Therapeutics GmbH
 AMP-Therapeutics GmbH Pharmaceuticals: MajorHealth Technology AMP-Therapeutics GmbH operates as a pharmaceutical company. It discovers and develops medicines and antibiotics for the treatment of drug resistant infections. The company was founded by Ralf A. Hoffmann in 2009 and is headquartered in Leipzig, Germany. | Oprichter | - |
Deutsche Bank AG (Broker)
 Deutsche Bank AG (Broker) Investment Banks/BrokersFinance Deutsche Bank AG (Broker) is the brokerage arm of Deutsche Bank AG (ETR: DBK) in Germany. Headquartered in Frankfurt, the firm was founded in 1870 and offers FX Prime Brokerage (FXPB) which enables clients to transact foreign exchange across an array of dealers utilizing Deutsche Bank credit lines to maintain anonymity, maximize operational and margin efficiency and reduce transactional costs. | Directeur van Onderzoek - Eigen Vermogen | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Deutsche Bank AG (Broker)
Deutsche Bank AG (Broker) Investment Banks/BrokersFinance Deutsche Bank AG (Broker) is the brokerage arm of Deutsche Bank AG (ETR: DBK) in Germany. Headquartered in Frankfurt, the firm was founded in 1870 and offers FX Prime Brokerage (FXPB) which enables clients to transact foreign exchange across an array of dealers utilizing Deutsche Bank credit lines to maintain anonymity, maximize operational and margin efficiency and reduce transactional costs. | Finance |
AMP-Therapeutics GmbH
AMP-Therapeutics GmbH Pharmaceuticals: MajorHealth Technology AMP-Therapeutics GmbH operates as a pharmaceutical company. It discovers and develops medicines and antibiotics for the treatment of drug resistant infections. The company was founded by Ralf A. Hoffmann in 2009 and is headquartered in Leipzig, Germany. | Health Technology |